Assignee

PF MEDICAMENT

FR183 patents

Top patents by PatentIndex Score

US7241444B2Jul 10, 2007

Anti-IGF-IR antibodies and uses thereof

PF MEDICAMENT95 citations97

US6020345AFeb 1, 2000

Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine

PF MEDICAMENT66 citations95

US6029662AFeb 29, 2000

Compressed-air powder inhaler

PF MEDICAMENT88 citations94

US5132116AJul 21, 1992

Tablets of the hydrophilic matrix type based on salbutamol and a process for their preparation

PF MEDICAMENT53 citations94

US6149911ANov 21, 2000

Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines

PF MEDICAMENT59 citations93

US6113911ASep 5, 2000

Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method

PF MEDICAMENT37 citations93

US5620985AApr 15, 1997

Antimitotic binary alkaloid derivatives from catharanthus roseus

PF MEDICAMENT55 citations93

US7553485B2Jun 30, 2009

Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof

PF MEDICAMENT18 citations92

US6599540B1Jul 29, 2003

Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer

PF MEDICAMENT44 citations92

US6589953B2Jul 8, 2003

Sulfonamides derived from benzocyclic or benzoheterocyclic acids, their preparation and application in therapeutics

PF MEDICAMENT29 citations92

US5308844AMay 3, 1994

Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazin-4-ones and their use in therapy

PF MEDICAMENT23 citations92

US5789412AAug 4, 1998

Piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them

PF MEDICAMENT92 citations91

US5641779AJun 24, 1997

Selective ligands of 5-HT1D -5-HT1B receptors derived from indolepiperazine which are useful medicaments

PF MEDICAMENT21 citations91

US6699506B1Mar 2, 2004

Pharmaceutical composition with extended release of Milnacipran

PF MEDICAMENT45 citations90

US5977106ANov 2, 1999

3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives

PF MEDICAMENT51 citations90

US5726177AMar 10, 1998

Indole-derived arylpiperazines as ligands for 5HT1 -like, 5HT1B and 5HT1D receptors

PF MEDICAMENT33 citations90

US5591743AJan 7, 1997

3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands

PF MEDICAMENT49 citations90

US5990173ANov 23, 1999

2,3,5-trimethyl-4-hydroxyanilide derivatives, preparation thereof and therapeutical use thereof

PF MEDICAMENT34 citations89

US5958736ASep 28, 1999

Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence

PF MEDICAMENT32 citations89

US7005452B2Feb 28, 2006

Use of the dextrogyral enantiomer of milnacipran for the preparation of a drug

PF MEDICAMENT29 citations88

US6127377AOct 3, 2000

Vinca alkaloid antimitotic halogenated derivatives

PF MEDICAMENT38 citations88

USD576799SSep 16, 2008

Interproximal brush

PF MEDICAMENT22 citations87

US4959175ASep 25, 1990

Solution for dialyses and use of peptides based on glycine for preparing it

PF MEDICAMENT78 citations86

US5364864ANov 15, 1994

1,4-disubstituted piperidines, their preparation and their application in therapy

PF MEDICAMENT48 citations85

US9011865B2Apr 21, 2015

Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer

PF MEDICAMENT6 citations84

US8361461B2Jan 29, 2013

Anti-IGF-IR antibodies and uses thereof

PF MEDICAMENT8 citations84

US5733567AMar 31, 1998

Biodegradable, controlled-release microspheres and process for preparing them

PF MEDICAMENT33 citations84

US5034541AJul 23, 1991

Method of preparing 1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethyl-cyclopropane-z

PF MEDICAMENT27 citations84

US7914784B2Mar 29, 2011

Anti-IGF-IR antibodies and uses thereof

PF MEDICAMENT10 citations83

US10202458B2Feb 12, 2019

IGF-1R antibody and its use as addressing vehicle for the treatment of cancer

PF MEDICAMENT9 citations82

US7456192B2Nov 25, 2008

3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof

PF MEDICAMENT9 citations82

US6107284AAug 22, 2000

Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments

PF MEDICAMENT16 citations82

US8034377B2Oct 11, 2011

DHA esters and use thereof in treatment and prevention of cardiovascular disease

PF MEDICAMENT7 citations79

US7309494B2Dec 18, 2007

Peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine

PF MEDICAMENT12 citations79

US6709675B1Mar 23, 2004

Thixotropic formulations for filling capsules

PF MEDICAMENT17 citations78

US12312336B2May 27, 2025

Inhibitors of RAF kinases

PF MEDICAMENT2 citations74

US5286735AFeb 15, 1994

Derivatives of 4-aminomethylpiperidine, their preparation and their use as therapeutics

PF MEDICAMENT17 citations74

US7854930B2Dec 21, 2010

Anti-igf-ir antibodies and uses thereof

PF MEDICAMENT7 citations73

US6448268B1Sep 10, 2002

Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists

PF MEDICAMENT7 citations73

US6008382ADec 28, 1999

Method for preparing 4'-Demethylepipodophyllotoxin from podophyllotoxin

PF MEDICAMENT8 citations73

US5059599AOct 22, 1991

Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their preparation and their use in therapy

PF MEDICAMENT12 citations73

US6303603B1Oct 16, 2001

3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors

PF MEDICAMENT7 citations72

US6191130B1Feb 20, 2001

Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5T H1A receptors

PF MEDICAMENT9 citations72

US5948806ASep 7, 1999

Treatment of Parkinson's disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan)

PF MEDICAMENT9 citations72

US5661172AAug 26, 1997

Use of efaroxan and derivatives thereof for the treatment of Alzheimer's disease

PF MEDICAMENT7 citations72

US4933440AJun 12, 1990

Immunomodulators obtained semisynthetically from a bacterial polysaccharide isolated from a non-encapsulated mutant strain of Klebsiella pneumoniae

PF MEDICAMENT10 citations72

US4734403AMar 29, 1988

Membrane polysaccharides which are useful as immunostimulants

PF MEDICAMENT10 citations72

Showing the top 50 of 183 patents by PatentIndex Score.

PF MEDICAMENT

Top patents by PatentIndex Score

Anti-IGF-IR antibodies and uses thereof

Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine

Compressed-air powder inhaler

Tablets of the hydrophilic matrix type based on salbutamol and a process for their preparation

Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines

Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method

Antimitotic binary alkaloid derivatives from catharanthus roseus

Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof

Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer

Indole derivatives as 5-HT1B and 5-HT1D agonists

Indole derivatives as 5-HT1B and 5-HT1D agonists

Powder and compressed-air inhaler

Sulfonamides derived from benzocyclic or benzoheterocyclic acids, their preparation and application in therapeutics

Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazin-4-ones and their use in therapy

Piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them

Selective ligands of 5-HT1D -5-HT1B receptors derived from indolepiperazine which are useful medicaments

Pharmaceutical composition with extended release of Milnacipran

3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives

Indole-derived arylpiperazines as ligands for 5HT1 -like, 5HT1B and 5HT1D receptors

3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands

2,3,5-trimethyl-4-hydroxyanilide derivatives, preparation thereof and therapeutical use thereof

Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence

Use of the dextrogyral enantiomer of milnacipran for the preparation of a drug

Vinca alkaloid antimitotic halogenated derivatives

Interproximal brush

Solution for dialyses and use of peptides based on glycine for preparing it

1,4-disubstituted piperidines, their preparation and their application in therapy

Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer

Anti-IGF-IR antibodies and uses thereof

Biodegradable, controlled-release microspheres and process for preparing them

Method of preparing 1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethyl-cyclopropane-z

Anti-IGF-IR antibodies and uses thereof

IGF-1R antibody and its use as addressing vehicle for the treatment of cancer

3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof

Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments

DHA esters and use thereof in treatment and prevention of cardiovascular disease

Peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine

Thixotropic formulations for filling capsules

Inhibitors of RAF kinases

Derivatives of 4-aminomethylpiperidine, their preparation and their use as therapeutics

Anti-igf-ir antibodies and uses thereof

Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists

Method for preparing 4&#39;-Demethylepipodophyllotoxin from podophyllotoxin

Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their preparation and their use in therapy

3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors

Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5T H1A receptors

Treatment of Parkinson&#39;s disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan)

Use of efaroxan and derivatives thereof for the treatment of Alzheimer&#39;s disease

Immunomodulators obtained semisynthetically from a bacterial polysaccharide isolated from a non-encapsulated mutant strain of Klebsiella pneumoniae

Membrane polysaccharides which are useful as immunostimulants

Method for preparing 4'-Demethylepipodophyllotoxin from podophyllotoxin

Treatment of Parkinson's disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan)

Use of efaroxan and derivatives thereof for the treatment of Alzheimer's disease